SunCar Partners with Visa to Empower ICBC Cardholder Benefits in China's Affluent Consumer Market

2025-03-05 SunCar Technology Group Inc. HaiPress

NEW YORK,March 3,2025 -- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA),an innovative leader in auto e-insurance and cloud-based B2B auto services in China,today announced its selection as the exclusive provider for the Visa Concierge Car Service Project,establishing a pivotal partnership with global payments leader Visa. This strategic alliance positions SunCar to deliver premium airport and high-speed rail transfer services to Industrial and Commercial Bank of China's (ICBC) high-net-worth cardholders nationwide,opening significant new revenue channels in China's lucrative premium services market.

This partnership represents a substantial expansion of SunCar's addressable market,providing direct access to ICBC's coveted Platinum and Black Gold cardholders—an elite customer segment with individual assets exceeding $1.1 million and credit card spending limits above $275,000.

"Securing this partnership with Visa,following their rigorous vendor evaluation process,validates our technology platform's superiority and service excellence," said Ye Zaichang,CEO of SunCar. "This high-profile collaboration enhances our market position with minimal additional capital expenditure,accelerating our path to increased shareholder value."

The exclusive partnership leverages SunCar's established nationwide service network and proprietary cloud-based technology platform,allowing for rapid scaling with limited incremental costs. The company's advanced AI-powered dispatch system ensures optimal resource allocation,maintaining premium service levels while maximizing operational efficiency across China's first-tier and emerging city markets.

China's premium services market continues to expand alongside the country's growing high-net-worth population,presenting substantial growth opportunities for well-positioned service providers.

About SunCar Technology Group Inc.

Founded in 2007,SunCar is transforming the customer journey for auto services and auto insurance in China,the largest passenger vehicle market in the world. SunCar develops and operates cloud-based platforms that seamlessly connect drivers with a wide range of auto services and insurance coverage options through a nationwide network of sales partners. As a result,SunCar has established itself as the leader in China in the B2B auto services market and the auto eInsurance market for electric vehicles. The Company's intelligent cloud platform empowers its enterprise clients to access and manage their customer database and offerings optimally,and drivers gain access to hundreds of services from tens of thousands of independent providers in a single application. For more information,please visit: https://suncartech.com.

Forward-Looking Statements

This press release contains information about the Company's view of its future expectations,plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including,but not limited to,risks and uncertainties associated with its ability to raise additional funding,its ability to maintain and grow its business,variability of operating results,its ability to maintain and enhance its brand,its development and introduction of new products and services,the successful integration of acquired companies,technologies and assets into its portfolio of products and services,marketing and other business development initiatives,competition in the industry,general government regulation,economic conditions,dependence on key personnel,the ability to attract,hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients,and its ability to protect its intellectual property. The Company encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission.

Contact Information:

SunCar:


Investor Relations: Ms. Hui Jiang


Email: IR@suncartech.com


Legal: Ms. Li Chen


Email: chenli@suncartech.com

U.S. Investor Relations


Matthew Abenante,IRC


President


Strategic Investor Relations,LLC


Tel: 347-947-2093


Email: matthew@strategic-ir.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright2009-2020Fresh life